Stocks and Investing
Stocks and Investing
Mon, September 19, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, September 16, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Seamus Fernandez Maintained (ALT) at Strong Buy with Decreased Target to $26 on, Sep 16th, 2022
Seamus Fernandez of Guggenheim, Maintained "Altimmune, Inc." (ALT) at Strong Buy with Decreased Target from $31 to $26 on, Sep 16th, 2022.
Seamus has made no other calls on ALT in the last 4 months.
There are 4 other peers that have a rating on ALT. Out of the 4 peers that are also analyzing ALT, 0 agree with Seamus's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Seamus
- Roger Song of "Jefferies" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, August 31st, 2022
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $50 on, Wednesday, August 17th, 2022
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $26 on, Friday, August 12th, 2022
- Yasmeen Rahimi of "Piper Sandler" Maintained at Buy with Decreased Target to $25 on, Wednesday, May 18th, 2022
Contributing Sources